Revenio Group Oyj - Notice to general meeting

Revenio Group Corporation: Notice of the Annual General Meeting

Revenio Group Corporation, Stock Exchange Release February 23, 2016 at 13.30

NOTICE OF THE ANNUAL GENERAL MEETING

Notice is given to the shareholders of Revenio Group Corporation of the annual
general meeting to be held on March 15, 2016, at 5 p.m. at Finlandia Hall,
Veranda 2 hall, Mannerheimintie 13 e, FI-00100 Helsinki, Finland (entrances M4
and K4). The reception of persons who have registered for the meeting and the
distribution of voting tickets will commence at 3.30 p.m.

Before the meeting at 4 p.m., Olli-Pekka Salovaara, CEO of Revenio Group
Corporation, Timo Hildén, CEO of Icare Finland Oy, Ari Kukkonen, R&D Director of
Revenio Research Oy and Ville-Pekka Seppä, R&D Manager of Revenio Research Oy
will give a presentation on Revenio Group Corporation's R&D projects. After the
annual general meeting is held, the shareholders will have the opportunity to
meet the managing directors of the Revenio Group Corporation at a coffee event.

A. Matters on the agenda of the general meeting

The following matters will be considered at the General Meeting:

1. Opening of the meeting

2. Calling the meeting to order

3. Election of the persons to confirm the minutes and to supervise the counting
of votes

4. Recording the legal convening of the meeting and quorum

5. Recording the attendance at the meeting and adoption of the list of votes

6. Presentation of the annual accounts, the Report of the Board of Directors,
and the auditor's report for the year 2015

- Review by the President and CEO.

7. Adoption of the annual accounts

8. Resolution on the use of the profit shown on the balance sheet and the
payment of dividend

The Board of Directors proposes to the AGM that a per-share dividend of EUR
0.70 be paid for the financial year 2015. The dividend is paid to those
shareholders who, on the dividend record date of March 17, 2016, are entered as
shareholders on the Company's shareholder register as held by Euroclear Finland
Ltd. The Board proposes that the dividend payment date be March 24, 2016.

9. Resolution on the discharge of the members of the Board of Directors and the
President and CEO from liability

10. Resolution on the remuneration of the members of the Board of Directors and
on the grounds for compensation of travel expenses

11. Resolution on the number of members of the Board of Directors

12. Election of the members of the Board of Directors

13. Resolution on the remuneration of the auditor

The Board of Directors proposes that remuneration for the auditor shall be paid
against the auditor's reasonable invoice.

14. Election of the auditor

The Board of Directors proposes PricewaterhouseCoopers Oy to be re-elected as
the auditor.

15. Authorizing the Board of Directors to decide to repurchase the Company's own
shares

The Board of Directors proposes that the AGM authorize the Board to decide to
repurchase a maximum of 795,392 of the Company's own shares in one or several
tranches using the Company's non-restricted equity capital.

The company may buy back shares in order to develop its capital structure,
finance and implement any corporate acquisitions or other transactions,
implement share-based incentive plans, or otherwise transfer or cancel them.

The company may buy back shares in public trading on marketplaces whose rules
and regulations allow the Company to trade in its own shares. In such a case,
the Company buys back shares through a directed purchase, that is, in a
proportion other than its shareholders' holdings in Company shares, with the
consideration for the shares based on their publicly quoted market price, in
such a manner that the minimum price of the purchased shares equals the lowest
market price quoted in public trading during the authorization period, and,
similarly, their highest price equals the highest market price quoted in public
trading during that period.

The Board proposes that the authorization be valid until April 30, 2017. This
authorization shall supersede the buyback authorization granted at the AGM of
March 19, 2015.

16. Authorization to the Board of Directors to decide on a share issue and on
the granting of stock options and other special rights giving entitlement to
shares

The Board of Directors proposes that the AGM authorize the Board to decide on a
share issue of a maximum of 795,392 shares or to grant special rights (including
stock options) entitling holders to shares as referred to in Chapter 10 Section
1 of the Companies Act, in one or several tranches.

This authorization is proposed to be used to finance and implement any
prospective corporate acquisitions or other transactions, to implement the
company's share-based incentive plans, or for other purposes determined by the
Board.

The authorization is also proposed to grant the Board the right to decide on all
terms and conditions governing said share issue and the granting of special
rights, including the subscribers or the grantees of said special rights and the
payable consideration. The authorization also includes the right to waive
shareholders' pre-emptive subscription rights and covers the issue of new shares
and the transfer of any shares that may be held by the company.

The Board proposes that the authorization be valid until April 30, 2017. This
authorization shall supersede the authorization to decide on a share issue and
on the granting of special rights giving entitlement to shares granted in the
AGM of March 19, 2015.


17. Closing of the meeting

B. Documents of the General Meeting

The abovementioned proposals for resolution on the AGM agenda and this notice
are available on the website of Revenio Group Corporation at www.revenio.fi.
Revenio Group Corporation's Annual Report, including the financial statements,
Report of the Board of Directors and auditor's report, will be available on the
website no later than February 23, 2016. Proposals for resolution and the
abovementioned documents will also be available at the AGM, and copies of them
as well as this notice will be sent to shareholders upon request. The Minutes of
the AGM will be available on the abovementioned website from March 29, 2016
onwards.

C. Instructions to meeting participants

1. Shareholders registered in the shareholder register

Shareholders who are registered in the Company's shareholder register maintained
by Euroclear Finland Ltd on March 3, 2016, have the right to attend the AGM.
Shareholders whose shares are registered in their personal book-entry accounts
in Finland are registered in the shareholder register of the Company.

Shareholders who are registered in the Company's shareholder register and wish
to participate in the AGM must register for the meeting no later than March
10, 2016 at 4:00 p.m., by which time registration notices need to have been
received. Registration options for the General Meeting are:

a) through the Company's website at www.revenio.fi
b) via e-mail to elina.kari@revenio.fi or
c) by mail to Revenio Group Corporation, General Meeting, Äyritie 22, FI-01510
Vantaa, Finland.

Upon registration, shareholders should give their name, personal identity code,
address, telephone number, name of assistant or proxy representative, if any,
and the personal identity code of the proxy representative. Personal information
given by shareholders to Revenio Group Corporation shall be used only in
connection with the General Meeting and with the processing of related
registrations. Shareholders, their representatives or proxy representatives must
be able to prove their identity and/or proxy authorization at the meeting
venue.

2. Holders of nominee-registered shares

A holder of nominee-registered shares has the right to participate in the AGM by
virtue of such shares based on which the holder would, on March 3, 2016, be
entitled to be registered in the shareholder register held by Euroclear Finland
Ltd. Moreover, in order to participate in the AGM, holders of nominee-registered
shares are required to be temporarily registered, based on such shares, in the
shareholder register held by Euroclear Finland Ltd, no later than March
10, 2016, at 10:00 a.m. For nominee-registered shares, this constitutes due
registration for the General Meeting.

Holders of nominee-registered shares are advised to request, without delay, all
necessary instructions pertaining to registration in the temporary shareholder
register, the issuing of proxy documents, and registration for the General
Meeting from their asset managers. The asset manager's account operator must
sign up holders of nominee-registered shares who wish to participate in the
General Meeting for registration to the Company's temporary shareholder register
no later than on the aforementioned date and time.

3. Proxy representation and powers of attorney

Shareholders may participate in the General Meeting and exercise their rights at
the meeting by way of proxy representation. A shareholder's proxy representative
shall present a dated power of attorney or shall otherwise in a reliable manner
prove that he/she is authorized to represent the shareholder. If a shareholder
participates in the General Meeting by way of several proxy representatives,
representing the shareholder with shares in different securities accounts, the
shares by which each proxy representative represents the shareholder must be
identified upon registration.

Proxy documents, if any, should be delivered as originals to Revenio Group
Corporation, General Meeting, Äyritie 22, FI-01510 Vantaa, Finland, before the
last date for registration.

4. Other instructions and information

Pursuant to Chapter 5, Section 25 of the Finnish Companies Act, a shareholder
who is present at the General Meeting has the right to request information on
matters on the meeting's agenda.

On the date of this notice, February 23, 2016, the total number of shares in
Revenio Group Corporation is 7,953,928, representing the same number of votes.


Vantaa, February 23, 2016

Revenio Group Corporation
Board of Directors

For further information, please contact:
President & CEO Olli-Pekka Salovaara, tel. +358 40 567 5520
olli-pekka.salovaara@revenio.fi
www.revenio.fi

DISTRIBUTION:
NASDAQ OMX Helsinki
Financial Supervisory Authority (FIN-FSA)
Principal media
www.revenio.fi

The Revenio Group in brief

Revenio is a Finnish, globally operating health technology corporation whose
worldwide success is based on a strongly patented intraocular pressure
measurement technology. The Revenio Group consists of Icare Finland Oy, Revenio
Research Oy and Oscare Medical Oy, in which Revenio holds a 53% interest. The
common denominators of Revenio's business operations include screening, follow-
up and the global need to make cost savings through preventive health care.
Revenio seeks vigorous growth in health technology. Revenio aims at developing
even more efficient and easily adopted methods for the early-stage detection of
diseases with significance for public health. The focus of Revenio's screening
technology is on the early detection of glaucoma, osteoporosis, skin cancer and
asthma, and the monitoring of these during the treatment process.

In 2015, the Revenio Group's net sales totaled MEUR 20.3, with its operating
margin for continuing operations standing at 28.4%. Revenio Group Corporation is
listed on Nasdaq Helsinki.


[HUG#1988487]